AGM
CTSO icon

Alpine Global Management’s Cytosorbents Corp CTSO Stock Holding History

Alpine Global Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-17,689
Closed -$115K – 128
2017
Q4 		$115K Buy
+17,689
New +$113K 0.03% 150

Other funds holding CTSO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Alpine Global Management's CTSO Position: Q1 2018 in Review

Alpine Global Management sold out of Cytosorbents Corp (CTSO) in Q1 2018, closing a stake of 17,689 shares — an estimated $115K sold.

Alpine Global Management first reported a position in CTSO in Q4 2017 and held it in 1 quarter. The position peaked at $115K in Q4 2017. 49 funds tracked by Wall St. Rank hold CTSO as of Q1 2018.

  • Alpine Global Management reported no remaining Cytosorbents Corp position as of Q1 2018 after selling out during the quarter.
  • Alpine Global Management sold 17,689 Cytosorbents Corp shares in Q1 2018, an estimated $115K.
  • Alpine Global Management first reported a position in Cytosorbents Corp in Q4 2017 and held it in 1 quarter.
  • Alpine Global Management's Cytosorbents Corp position peaked at $115K in Q4 2017.
  • 49 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2018.

Based on Alpine Global Management's 13F filing for Q1 2018, filed 16 May 2018.